249 related articles for article (PubMed ID: 10807805)
1. A multicenter trial with a somatostatin analog (99m)Tc depreotide in the evaluation of solitary pulmonary nodules.
Blum J; Handmaker H; Lister-James J; Rinne N
Chest; 2000 May; 117(5):1232-8. PubMed ID: 10807805
[TBL] [Abstract][Full Text] [Related]
2. The utility of a somatostatin-type receptor binding peptide radiopharmaceutical (P829) in the evaluation of solitary pulmonary nodules.
Blum JE; Handmaker H; Rinne NA
Chest; 1999 Jan; 115(1):224-32. PubMed ID: 9925088
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of Tc-99m depreotide scintigraphy in the evaluation of solitary pulmonary nodules.
Grewal RK; Dadparvar S; Yu JQ; Babaria CJ; Cavanaugh T; Sherman M; Jacobstein J
Cancer J; 2002; 8(5):400-4. PubMed ID: 12416898
[TBL] [Abstract][Full Text] [Related]
4. Limited value of ⁹⁹mTc depreotide single photon emission CT compared with CT for the evaluation of pulmonary lesions.
Harders SW; Madsen HH; Hjorthaug K; Rehling M; Rasmussen TR; Pedersen U; Pilegaard HK; Meldgaard P; Baandrup UT; Rasmussen F
Br J Radiol; 2012 Jul; 85(1015):e307-13. PubMed ID: 22745210
[TBL] [Abstract][Full Text] [Related]
5. The solitary pulmonary nodule--is it malignant or benign? Diagnostic performance of Tc-depreotide SPECT.
Naalsund A; Maublant J
Respiration; 2006; 73(5):634-41. PubMed ID: 16679755
[TBL] [Abstract][Full Text] [Related]
6. Efficiency of 18F-FDG and 99mTc-depreotide SPECT in the diagnosis of malignancy of solitary pulmonary nodules.
Halley A; Hugentobler A; Icard P; Porret E; Sobrio F; Lerochais JP; Bouvard G; Zalcman G; Agostini D
Eur J Nucl Med Mol Imaging; 2005 Sep; 32(9):1026-32. PubMed ID: 15877227
[TBL] [Abstract][Full Text] [Related]
7. [Fusion of pulmonary scintigraphy with Tc99m-depreotide imaging with CT scan in recognizing solitary pulmonary nodule].
Szaluś N; Chciałowski A; From S; Zagrodzka M; Pietrzykowski J; Dziuk E
Pol Merkur Lekarski; 2008 Oct; 25(148):330-4. PubMed ID: 19145931
[TBL] [Abstract][Full Text] [Related]
8. Comparative evaluation of 99mTc-depreotide and 201Tl chloride single photon emission tomography in the characterization of pulmonary lesions.
Boundas D; Karatzas N; Moralidis E; Arsos G; Drevelengas A; Pistevou-Gompaki K; Karakatsanis C
Nucl Med Commun; 2007 Jul; 28(7):533-40. PubMed ID: 17538394
[TBL] [Abstract][Full Text] [Related]
9. The utility of 99mTc depreotide compared with F-18 fluorodeoxyglucose positron emission tomography and surgical staging in patients with suspected non-small cell lung cancer.
Kahn D; Menda Y; Kernstine K; Bushnell D; McLaughlin K; Miller S; Berbaum K
Chest; 2004 Feb; 125(2):494-501. PubMed ID: 14769730
[TBL] [Abstract][Full Text] [Related]
10. Solitary pulmonary nodules: meta-analytic comparison of cross-sectional imaging modalities for diagnosis of malignancy.
Cronin P; Dwamena BA; Kelly AM; Carlos RC
Radiology; 2008 Mar; 246(3):772-82. PubMed ID: 18235105
[TBL] [Abstract][Full Text] [Related]
11. Role of scintigraphy with technetium-99m depreotide in the diagnosis and management of patients with suspected lung cancer.
Axelsson R; Herlin G; Bååth M; Aspelin P; Kölbeck KG
Acta Radiol; 2008 Apr; 49(3):295-302. PubMed ID: 18365818
[TBL] [Abstract][Full Text] [Related]
12. Role of nuclear medicine in the evaluation of the solitary pulmonary nodule.
Goldsmith SJ; Kostakoglu L
Semin Ultrasound CT MR; 2000 Apr; 21(2):129-38. PubMed ID: 10776885
[TBL] [Abstract][Full Text] [Related]
13. Tc-99m depreotide SPECT/CT for lymph node staging of non-small-cell lung cancer.
Apostolopoulos DJ; Koletsis EN; Spyridonidis T; Paschali A; Papandrianos N; Stamou E; Vassilakos PJ; Dougenis D
Ann Nucl Med; 2014 Jun; 28(5):463-71. PubMed ID: 24668640
[TBL] [Abstract][Full Text] [Related]
14. Quantitative assessment of 99mTc-depreotide uptake in patients with non-small-cell lung cancer: immunohistochemical correlations.
Herlin G; Kölbeck KG; Menzel PL; Svensson L; Aspelin P; Capitanio A; Axelsson R
Acta Radiol; 2009 Oct; 50(8):902-8. PubMed ID: 19707908
[TBL] [Abstract][Full Text] [Related]
15. Integrated multislice CT and Tc-99m Sestamibi SPECT-CT evaluation of solitary pulmonary nodules.
Sergiacomi G; Schillaci O; Leporace M; Laviani F; Carlani M; Manni C; Danieli R; Simonetti G
Radiol Med; 2006 Mar; 111(2):213-24. PubMed ID: 16671379
[TBL] [Abstract][Full Text] [Related]
16. Somatostatin receptor imaging of non-small cell lung cancer with 99mTc depreotide.
Menda Y; Kahn D
Semin Nucl Med; 2002 Apr; 32(2):92-6. PubMed ID: 11965604
[TBL] [Abstract][Full Text] [Related]
17. Contribution of (99m)Tc-depreotide (Neospect) scintigraphy in lung cancer staging.
Karathanos E; Datseris I; Vlontzou E; Zisimopoulos A; Georgiou E
J BUON; 2010; 15(1):147-52. PubMed ID: 20414943
[TBL] [Abstract][Full Text] [Related]
18. A visual and semi-quantitative assessment of (99m)Tc-EDDA/HYNIC-TOC scintigraphy in differentiation of solitary pulmonary nodules.
Płachcińska A; Mikołajczak R; Kozak J; Rzeszutek K; Kuśmierek J
Nucl Med Rev Cent East Eur; 2004; 7(2):143-50. PubMed ID: 15968601
[TBL] [Abstract][Full Text] [Related]
19. Technetium-99m depreotide imaging by single photon emission tomography/low resolution computed tomography in malignant lymphomas: comparison with gallium-67 citrate.
Apostolopoulos DJ; Papandrianos NI; Symeonidis A; Spyridonidis T; Alexiou S; Zampakis P; Savvopoulos C; Vassilakos PJ; Matsouka P
Ann Nucl Med; 2010 Nov; 24(9):639-47. PubMed ID: 20799079
[TBL] [Abstract][Full Text] [Related]
20. Technetium-99m tetrofosmin single photon emission computed tomography in the evaluation of suspected lung cancer.
Schillaci O; Monteleone F; D'Andrea N; Picardi V; Cangemi R; Cangemi V; Scopinaro F
Cancer Biother Radiopharm; 1999 Apr; 14(2):129-34. PubMed ID: 10850296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
